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After publication of our work [1], we noted that panel C
from figure 4 (see Figure 1) was missing. We have now
added the corrected figure.
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Figure 4. 2G12 neutralizes HIV-1 JR-CSF effectively in a post- CD4 assay format. The neutralization activity of mAbs A)  b12, B) X5, and C) 2G12 was assessed in the standard  (closed circles) and post-CD4 (open circles) neutralization  formats Figure 1
Figure 4. 2G12 neutralizes HIV-1 JR-CSF effectively in a post-
CD4 assay format. The neutralization activity of mAbs A) 
b12, B) X5, and C) 2G12 was assessed in the standard 
(closed circles) and post-CD4 (open circles) neutralization 
formats. Results are expressed as % of residual infection, 
with 100% representing infection in the absence of mAb. 
Results are representative of two experiments.
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